RSS
14 Jul 2022

Zylorion Announces Filing of U.S. Provisional Patent For Novel Second-Generation Psilocybin-Based Compound

Author: admintech | Filed under: Press Release

CALGARY, AB, July 14, 2022 /PRNewswire/ – PsiloTec Health Solutions Inc., operating as Zylorion Health, (“Zylorion” or the “Company”), a precision mental health care and psychedelic therapy focused innovator, is pleased to announce the filing of the Company’s third provisional patent…

This entry was posted on Thursday, July 14th, 2022 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»